What Happened?
Redwood City, CA-based Adverum Resigned Leone Patterson as President and Chief Financial Officer
About the Company
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.
About the Person
Leone Patterson is President and Chief Financial Officer at Adverum. Previously, Leone held various senior HR leadership roles in the industry.
Info Source
News
Short Profile